Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
40.17 EUR | +0.75% |
|
+3.00% | +1.53% |
06-25 | Orion Obtains License to Market Navamedic's Parkinson's Disease Drug in Europe | MT |
06-24 | Navamedic ASA and Orion Corporation Sign License & Supply Agreement for Flexilev in Europe | CI |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Dividend / Share (DPS) - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- ORNBV Stock
- Revisions Orion Oyj